|
妊娠期D-二聚体显著升高1例并文献复习
|
Abstract:
分析青岛大学附属医院收治的1例妊娠期D-二聚体显著升高孕妇的临床资料并进行文献复习,探讨孕期高D-二聚体预防不良妊娠结局的临床管理和决策方法。方法:回顾性分析2024年01月04日青岛大学附属医院收治的1例孕37 + 2周D-二聚体显著升高孕妇的病例资料,并复习国内外相关文献,分析孕期高D-二聚体产生原因、可能发生的不良妊娠结局及预防措施。结果:患者入院后完善相关辅助检查,予抗凝治疗,监测胎心、胎动变化,后D-二聚体逐渐下降并维持稳定,于孕39周经剖宫产终止妊娠。术后产妇及新生儿病情稳定。新生儿生后Apgar评分1、5分钟均10分,产妇宫缩好,阴道流血少,术后恢复良好出院。出院后新生儿生长发育与同龄儿无明显差异。通过复习国内外文献资料,了解妊娠期及产褥期D-二聚体区间及高D-二聚体孕妇不良妊娠结局预防措施。
The clinical data of a pregnant woman with a significant increase in D-dimer during pregnancy admitted to the Affiliated Hospital of Qingdao University were analyzed and the literature was reviewed to explore the clinical management and decision-making methods of high D-dimer during pregnancy to prevent adverse pregnancy outcomes. Methods: The case data of a pregnant woman with a significant increase in D-dimer at 37 + 2 weeks gestation admitted to the Affiliated Hospital of Qingdao University on January 04, 2024 were retrospectively analyzed, and relevant literature at home and abroad were reviewed to analyze the causes of high D-dimer during pregnancy, possible adverse pregnancy outcomes and preventive measures. Results: After admission, the relevant auxiliary examination was completed, anticoagulant treatment was given, fetal heart rate and fetal movement were monitored, D-dimer gradually decreased and remained stable, and pregnancy was terminated by cesarean section at 39 weeks of gestation. The condition of the mother and newborn was stable after the operation. The Apgar score of the newborn was 10 points at 1 and 5 minutes after birth. The puerperal contraction was good, the vaginal bleeding was less, and the postoperative recovery was good. After discharge, there was no significant difference between the growth and development of newborns and those of the same age. Through reviewing the literature at home and abroad, to understand the D-dimer interval during pregnancy and the puerperal period and the prevention measures of adverse pregnancy outcome in pregnant women with high D-dimer.
[1] | 陈潇, 王兰兰, 辛刚. D-二聚体在妊娠期临床应用中的研究现状[J]. 现代妇产科进展, 2022, 31(4): 313-315. |
[2] | Wang, M., Lu, S., Li, S. and Shen, F. (2013) Reference Intervals of D-Dimer during the Pregnancy and Puerperium Period on the STA-R Evolution Coagulation Analyzer. Clinica Chimica Acta, 425, 176-180. https://doi.org/10.1016/j.cca.2013.08.006 |
[3] | 申南, 范玲. 妊娠晚期D-二聚体异常升高与不良妊娠结局关系的研究[J]. 中国妇产科临床杂志, 2016, 17(3): 204-206. |
[4] | 陈真, 龚阳阳, 漆洪波. 产科中发生高凝状态的因素研究[J]. 实用妇产科杂志, 2022, 38(4): 241-244. |
[5] | 周莉, 范玲. 妊娠期凝血功能特点[J]. 中华产科急救电子杂志, 2014, 3(2): 81-85. |
[6] | Warren, B.B., Moyer, G.C. and Manco-Johnson, M.J. (2023) Hemostasis in the Pregnant Woman, the Placenta, the Fetus, and the Newborn Infant. Seminars in Thrombosis and Hemostasis, 49, 319-329. https://doi.org/10.1055/s-0042-1760332 |
[7] | 狄文, 吴珈悦. 妇产科静脉血栓栓塞症发生的高危因素[J]. 中国实用妇科与产科杂志, 2018, 34(7): 714-717. |
[8] | 中国营养学会肥胖防控分会, 中国营养学会临床营养分会, 中华预防医学会行为健康分会, 等. 中国居民肥胖防治专家共识[J]. 西安交通大学学报(医学版), 2022, 43(4): 619-631. |
[9] | 梁胜男, 郑薇, 宋伟, 王小新, 郭翠梅, 严欣, 张黎锐, 李光辉. 不同程度肥胖女性孕期增重与不良妊娠结局的比较研究[J]. 北京医学, 2024, 46(11): 958-964. |
[10] | Vinatier, D., Dufour, P., Cosson, M. and Houpeau, J.L. (2001) Antiphospholipid Syndrome and Recurrent Miscarriages. European Journal of Obstetrics & Gynecology and Reproductive Biology, 96, 37-50. https://doi.org/10.1016/s0301-2115(00)00404-8 |
[11] | 乔斌, 龚卫杰, 李艳. 狼疮抗凝物阳性系统性红斑狼疮患者凝血功能研究[J]. 国际检验医学杂志, 2020, 41(12): 1457-1459, 1464. |
[12] | 张晶, 蔡建兴, 罗琳华, 罗振宇, 黄小丽. 狼疮抗凝物及其他凝血指标与复发性流产的相关性研究[J]. 中国妇幼保健, 2024, 39(2): 278-281. |
[13] | Ruiz‐Irastorza, G., Hunt, B.J. and Khamashta, M.A. (2007) A Systematic Review of Secondary Thromboprophylaxis in Patients with Antiphospholipid Antibodies. Arthritis Care & Research, 57, 1487-1495. https://doi.org/10.1002/art.23109 |
[14] | 朱虹, 宣荣荣, 刘莉萍, 王琳, 蒋伟春, 周宁. 妊娠高血压综合征与妊娠期糖尿病患者凝血功能检测的价值探讨[J]. 中华全科医学, 2019, 17(10): 1711-1713. |
[15] | 秦秀云, 贾晶. 妊娠期高血压疾病患者凝血功能指标、血栓前状态指标水平变化及意义[J]. 山东医药, 2018, 58(21): 72-74. |
[16] | 胡晓霞, 尹丽华, 胡艺方, 张宜生. 妊娠期糖尿病凝血功能的变化及其临床意义[J]. 现代实用医学, 2024, 36(9): 1223-1225. |
[17] | 王虹, 妊娠期糖尿病患者血小板参数变化及临床意义[J]. 吉林医学, 2010, 31(7): 928-929. |
[18] | 张健, 徐太会. 妊娠高血压综合征(妊高征)及妊娠期糖尿病孕妇血小板功能状态和血小板活化情况[J]. 世界最新医学信息文摘, 2015, 15(74): 108-109. |
[19] | 米玉红, 文洪林, 裴晓璐. 肺血栓栓塞症诊疗全流程出凝血功能检测专家共识[J]. 临床急诊杂志, 2025, 26(4): 231-243. |
[20] | 丁婷婷. 高龄初产妇产后发生下肢深静脉血栓现状及影响因素分析[J]. 中国妇幼保健, 2025, 40(7): 1282-1286. |
[21] | 孙平, 尹传政, 宋自芳. 2024美国胃肠病学会临床实践指南《肝脏局灶性病变》更新解读[J]. 临床外科杂志, 2025, 33(1): 32-35. |
[22] | 柏露, 张乐萍. Kasabach-Merritt现象[J]. 中国小儿血液与肿瘤杂志, 2015, 20(2): 57-59. |
[23] | 王学军, 胡晟, 陈轶晖, 环韵峰, 何凯, 廖周俊, 张小文. 肝血管瘤治疗研究进展[J]. 现代医药卫生, 2022, 38(16): 2808-2813. |
[24] | Hall, G.W. (2001) Kasabach-Merritt Syndrome: Pathogenesis and Management. British Journal of Haematology, 112, 851-862. https://doi.org/10.1046/j.1365-2141.2001.02453.x |
[25] | 江瑛, 任雪琼, 林洁琼. 不同年龄孕妇妊娠晚期D-二聚体和凝血功能变化及对妊娠结局的影响[J]. 中国妇幼保健, 2024, 39(21): 4184-4187. |
[26] | 马艳. 孕晚期血浆D-二聚体水平对不良妊娠结局的影响[J]. 中国冶金工业医学杂志, 2019, 36(5): 610-611. |
[27] | 韦海棠, 邬华, 龚天柳. 产前血D-二聚体水平对不良妊娠结局预测价值的研究[J]. 中国临床新医学, 2021, 14(12): 1217-1220. |
[28] | Zhang, Y., Li, T., Yue, C. and Liu, Y. (2024) Associations of Serum D-Dimer and Glycosylated Hemoglobin Levels with Third-Trimester Fetal Growth Restriction in Gestational Diabetes Mellitus. World Journal of Diabetes, 15, 914-922. https://doi.org/10.4239/wjd.v15.i5.914 |
[29] | Zhu, Y., Liu, Z., Miao, C., Wang, X., Liu, W., Chen, S., et al. (2023) Trajectories of Maternal D-Dimer Are Associated with the Risk of Developing Adverse Maternal and Perinatal Outcomes: A Prospective Birth Cohort Study. Clinica Chimica Acta, 543, Article ID: 117324. https://doi.org/10.1016/j.cca.2023.117324 |
[30] | 方胜英, 杨晓琴. 阿司匹林联合肝素对高D-二聚体复发性流产TXA2、PGI2的影响[J]. 中外医学研究, 2017, 15(21): 31-33. |
[31] | 李春, 吴丽虾, 杨玲玲, 吴泉锋. 低分子肝素钠联合阿司匹林防治子痫前期孕妇发生胎儿生长受限的效果观察[J]. 中国妇幼保健, 2025, 40(2): 209-212. |
[32] | 王婷, 刘岩. 低分子量肝素钠联合小剂量阿司匹林治疗胎儿生长受限的效果及对孕妇羊水指数、凝血功能的影响研究[J]. 中国实用医药, 2025, 20(1): 15-20. |
[33] | 赵苏, 相李平. 子痫前期患者运用小剂量阿司匹林联合低分子肝素钠方案治疗的效果评价[J]. 中国医药指南, 2025, 23(4): 39-41. |
[34] | 罗希, 周从容, 黄永俐, 吕晶, 潘莉娜. 早期抗凝干预治疗对冻融胚胎移植前高D-二聚体患者妊娠结局的影响[J]. 国际生殖健康/计划生育杂志, 2019, 38(2): 104-107. |
[35] | 董芳. 阿司匹林联合低分子肝素治疗复发性流产妊娠患者的临床疗效及其对甲状腺激素的影响[J]. 临床合理用药杂志, 2022, 15(6): 140-143. |
[36] | 唐建. 低分子肝素联合阿司匹林治疗复发性流产的效果分析[J]. 名医, 2022(3): 171-173. |
[37] | 田新平, 赵久良, 李梦涛, 宋亦军, 刘俊涛, 曾小峰. 《2022中国系统性红斑狼疮患者生殖与妊娠管理指南》解读[J]. 协和医学杂志, 2023, 14(3): 504-513. |
[38] | 黄文娟, 卢莹莹. 维生素D联合依诺肝素钠治疗对早发型重度子痫前期患者血胎盘生长因子D-二聚体及妊娠结局的影响[J]. 中国药物与临床, 2024, 24(20): 1331-1336. |
[39] | 郑洁, 陆平, 李玉梅. 大剂量叶酸口服联合低分子肝素治疗复发性流产患者的临床应用价值[J]. 医学理论与实践, 2025, 38(1): 98-100. |
[40] | 郑蕊, 徐运茹, 李秀芬. 小剂量阿司匹林联合钙剂、维生素E治疗妊娠期高血压疾病的效果[J]. 临床医学, 2025, 45(1): 99-101. |
[41] | 张莹云. 孕产妇孕早、中、晚期D-二聚体、凝血四项指标检验结果及临床意义分析[J]. 哈尔滨医药, 2024, 44(3): 17-19. |
[42] | 蔡小桃, 雷敏宜, 许怀通, 陈可谊. 妊娠期糖尿病孕妇孕中晚期及产褥早期血浆D-二聚体水平研究[J]. 中国实用医药, 2018, 13(28): 22-24. |
[43] | 柏胜梅. 低分子肝素联合硝苯地平控释片对妊娠期高血压患者血压及母婴结局的影响[J]. 山西医药杂志, 2024, 53(13): 1018-1021. |
[44] | 冯爱萍. 初诊2型糖尿病患者胰岛素强化治疗对凝血功能的影响研究[D]: [硕士学位论文]. 泰安: 泰山医学院, 2012. |
[45] | 罗晓群, 李震乾, 谭智毅. 妊娠期血糖血脂异常与凝血四项关系的变化及临床意义[J]. 实用医技杂志, 2014, 21(4): 406-407. |